{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:01:51Z","timestamp":1784718111074,"version":"3.55.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["WL-HBBD-2021001K"],"award-info":[{"award-number":["WL-HBBD-2021001K"]}],"id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["22ZR1459300"],"award-info":[{"award-number":["22ZR1459300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["shslczdzk04901"],"award-info":[{"award-number":["shslczdzk04901"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jep.2024.117857","type":"journal-article","created":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T22:37:36Z","timestamp":1707691056000},"page":"117857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Mechanistic study of the anti-excitatory amino acid toxicity of Bushen Zhichan decoction for Parkinson's disease based on the transcriptional regulation of EAAT1 by YY1"],"prefix":"10.1016","volume":"325","author":[{"given":"Leilei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0186-1842","authenticated-orcid":false,"given":"Wentao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2024.117857_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jep.2024.117857_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jep.2024.117857_bib3","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.3390\/cells11172722","article-title":"Carnitine protects against MPP+-Induced neurotoxicity and inflammation by promoting primary ciliogenesis in SH-SY5Y cells","volume":"11","author":"Bae","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jep.2024.117857_bib4","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1007\/s12035-022-02851-1","article-title":"Exploring the role of ubiquitin-proteasome system in Parkinson's disease","volume":"59","author":"Behl","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jep.2024.117857_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41419-021-03441-0","article-title":"Expanding the role of proteasome homeostasis in Parkinson's disease: beyond protein breakdown","volume":"12","author":"Bi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jep.2024.117857_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/13543784.2012.651457","article-title":"New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors","volume":"21","author":"Blandini","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.jep.2024.117857_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tins.2013.06.003","article-title":"Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems","volume":"36","author":"Brichta","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jep.2024.117857_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.devcel.2013.12.002","article-title":"Contrasting the glial response to axon injury in the central and peripheral nervous systems","volume":"28","author":"Brosius Lutz","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jep.2024.117857_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22064","article-title":"Structure and allosteric inhibition of excitatory amino acid transporter 1","volume":"544","author":"Canul-Tec","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jep.2024.117857_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/jcbfm.2011.121","article-title":"Mechanisms of glutamate efflux at the blood-brain barrier: involvement of glial cells","volume":"32","author":"Cohen Kashi Malina","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.jep.2024.117857_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jep.2024.117857_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","article-title":"Parkinson's disease: autoimmunity and neuroinflammation","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jep.2024.117857_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2023.103883","article-title":"Recovery of motor function is associated with rescue of glutamate biomarkers in the striatum and motor cortex following treatment with Mucuna pruriens in a murine model of Parkinsons disease","volume":"126","author":"Denne","year":"2023","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jep.2024.117857_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic-A call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jep.2024.117857_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00702-014-1176-4","article-title":"Therapeutic potential of targeting glutamate receptors in Parkinson's disease","volume":"121","author":"Finlay","year":"2014","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.jep.2024.117857_bib16","first-page":"8","article-title":"Modified Bushen Zhichan Decoction in the treatment of Parkinson's disease with syndrome of deficiency of liver and kidney: a randomized controlled study","volume":"35","author":"Gao","year":"2021","journal-title":"Acad. J. Shanghai Univ. Tradit. Chin. Med."},{"key":"10.1016\/j.jep.2024.117857_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255555","article-title":"NEURODEGENERATION. Alzheimer's and Parkinson's diseases: the prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jep.2024.117857_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12974-020-01819-z","article-title":"A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation","volume":"17","author":"Goshi","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jep.2024.117857_bib19","first-page":"12","article-title":"TCM syndrome distribution and rule of medication in Parkinson's disease","volume":"47","author":"Gu","year":"2013","journal-title":"Shanghai J. Tradit. Chin. Med."},{"key":"10.1016\/j.jep.2024.117857_bib20","first-page":"219","article-title":"Advances in the treatment of Parkinson's disease from liver and kidney treatment","volume":"21","author":"Guo","year":"2019","journal-title":"J. Liaoning Univ. Tradit. Chin. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.jep.2024.117857_bib21","first-page":"S3","article-title":"What causes cell death in Parkinson's disease?","volume":"64","author":"Gupta","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jep.2024.117857_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.gde.2009.03.008","article-title":"The genetics of Parkinson's syndromes: a critical review","volume":"19","author":"Hardy","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jep.2024.117857_bib23","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1471-4159.2008.05486.x","article-title":"The Yin and Yang of YY1 in the nervous system","volume":"106","author":"He","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jep.2024.117857_bib24","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/brain\/awt134","article-title":"Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins","volume":"136","author":"Hurley","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jep.2024.117857_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","article-title":"Glutamate-induced excitotoxicity in Parkinson's disease: the role of glial cells","volume":"144","author":"Iovino","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jep.2024.117857_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jep.2024.117857_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jep.2024.117857_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.WNL.0000172638.58172.5a","article-title":"Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures","volume":"65","author":"Jen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2024.117857_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuro.2018.05.001","article-title":"Valproic acid attenuates manganese-induced reduction in expression of GLT-1 and GLAST with concomitant changes in murine dopaminergic neurotoxicity","volume":"67","author":"Johnson","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jep.2024.117857_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jep.2024.117857_bib31","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1007\/s12035-017-0709-x","article-title":"Arundic acid increases expression and function of astrocytic glutamate transporter EAAT1 via the ERK, Akt, and NF-\u03baB pathways","volume":"55","author":"Karki","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jep.2024.117857_bib32","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/glia.22679","article-title":"Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes","volume":"62","author":"Karki","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.jep.2024.117857_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1471-4159.1998.70020745.x","article-title":"Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism","volume":"70","author":"Kawai","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jep.2024.117857_bib34","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1046\/j.1471-4159.2003.02128.x","article-title":"Transcriptional regulation of human excitatory amino acid transporter 1 (EAAT1): cloning of the EAAT1 promoter and characterization of its basal and inducible activity in human astrocytes","volume":"87","author":"Kim","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jep.2024.117857_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.autneu.2015.05.005","article-title":"Purinergic signalling in the enteric nervous system (An overview of current perspectives)","volume":"191","author":"King","year":"2015","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.jep.2024.117857_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-7091-6467-9_24","article-title":"The role of glutamate in dementia","volume":"53","author":"Kornhuber","year":"1998","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.jep.2024.117857_bib37","article-title":"Autophagy in Parkinson's disease","volume":"13","author":"Lior","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jep.2024.117857_bib38","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1152\/physrev.00050.2005","article-title":"(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms","volume":"86","author":"Lang","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jep.2024.117857_bib39","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.biocel.2010.09.016","article-title":"Astrocytes: glutamate transport and alternate splicing of transporters","volume":"42","author":"Lee","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jep.2024.117857_bib40","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2024.117857_bib41","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.addr.2009.07.016","article-title":"The failure of mitochondria leads to neurodegeneration: do mitochondria need a jump start?","volume":"61","author":"Lee","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jep.2024.117857_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108275","article-title":"Targeting mGluR 2\/3 for treatment of neurodegenerative and neuropsychiatric diseases","volume":"239","author":"Li","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jep.2024.117857_bib43","article-title":"Effects of combined Bushen Zhichan recipe and Levodopa in a rodent model of Parkinson disease: potential mechanisms","volume":"26","author":"Li","year":"2020","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.jep.2024.117857_bib44","first-page":"7096","article-title":"Effect of Bushen Zhichan Prescription on neuroprotection and anti-excitatory amino acid in mice with Parkinson's disease","volume":"54","author":"Liu","year":"2023","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"10.1016\/j.jep.2024.117857_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2003.12.007","article-title":"Glutamate transporters: animal models to neurologic disease","volume":"15","author":"Maragakis","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jep.2024.117857_bib46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/1073858408322839","article-title":"Glial cells as players in parkinsonism: the \u201cgood,\u201d the \u201cbad,\u201d and the \u201cmysterious\u201d glia","volume":"14","author":"Mena","year":"2008","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jep.2024.117857_bib47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3892\/ol.2016.5383","article-title":"Neuroprotective effect of matrine on MPTP-induced Parkinson's disease and on Nrf2 expression","volume":"13","author":"Meng","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jep.2024.117857_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2009.06.005","article-title":"Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease","volume":"219","author":"Meredith","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jep.2024.117857_bib49","doi-asserted-by":"crossref","first-page":"15662","DOI":"10.1074\/jbc.RA120.015552","article-title":"Astrocyte-specific deletion of the transcription factor Yin Yang 1 in murine substantia nigra mitigates manganese-induced dopaminergic neurotoxicity","volume":"295","author":"Pajarillo","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jep.2024.117857_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.03.002","article-title":"The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: potential targets for neurotherapeutics","volume":"161","author":"Pajarillo","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jep.2024.117857_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5498\/wjp.v8.i2.51","article-title":"Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders","volume":"8","author":"Parkin","year":"2018","journal-title":"World J. Psychiatr."},{"key":"10.1016\/j.jep.2024.117857_bib52","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3390\/cells9092037","article-title":"Gateways for glutamate neuroprotection in Parkinson's disease (PD): essential role of EAAT3 and NCX1 revealed in an in vitro model of PD","volume":"9","author":"Piccirillo","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jep.2024.117857_bib53","article-title":"Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson's disease","volume":"38","author":"Rishi","year":"2016","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jep.2024.117857_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/187152707780619326","article-title":"Gliogenesis and glial pathology in depression","volume":"6","author":"Rajkowska","year":"2007","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.jep.2024.117857_bib55","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nurt.2010.07.001","article-title":"Astrocytes and therapeutics for Parkinson's disease","volume":"7","author":"Rappold","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"Suppl. 3","key":"10.1016\/j.jep.2024.117857_bib56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10513","article-title":"Limitations of current Parkinson's disease therapy","volume":"53","author":"Rascol","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jep.2024.117857_bib57","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1474-4422(18)30355-7","article-title":"The burden of Parkinson's disease: a worldwide perspective","volume":"17","author":"Rocca","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jep.2024.117857_bib58","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for Astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.jep.2024.117857_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.tins.2011.03.002","article-title":"Shaping the synaptic signal: molecular mobility inside and outside the cleft","volume":"34","author":"Rusakov","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jep.2024.117857_bib60","doi-asserted-by":"crossref","first-page":"15324","DOI":"10.1073\/pnas.011400198","article-title":"Sulfhydryl modification of V449C in the glutamate transporter EAAT1 abolishes substrate transport but not the substrate-gated anion conductance","volume":"98","author":"Seal","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jep.2024.117857_bib61","first-page":"233","article-title":"Update on the neurobiology of schizophrenia: a role for extracellular microdomains","volume":"53","author":"Shan","year":"2012","journal-title":"Minerva Psichiatr."},{"key":"10.1016\/j.jep.2024.117857_bib62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01345245","article-title":"Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism","volume":"14","author":"Sonsalla","year":"1998","journal-title":"Amino Acids"},{"key":"10.1016\/j.jep.2024.117857_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuroscience.2023.10.007","article-title":"Gene signals and SNPs associated with Parkinson's disease: a nutrigenomics and computational prospective insights","volume":"533","author":"Subramaniyan","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.jep.2024.117857_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuroscience.2008.02.075","article-title":"Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies","volume":"158","author":"Teichberg","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.jep.2024.117857_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.31887\/DCNS.2017.19.1\/rpal","article-title":"The potential role of neuroinflammation and transcription factors in Parkinson disease","volume":"19","author":"Tiwari","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jep.2024.117857_bib66","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.3390\/ijms21249607","article-title":"The regulation of astrocytic glutamate transporters in Health and neurodegenerative diseases","volume":"21","author":"Todd","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jep.2024.117857_bib67","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1471-4159.2005.03370.x","article-title":"A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake","volume":"95","author":"Vallejo-Illarramendi","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jep.2024.117857_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.592164","article-title":"The why of YY1: mechanisms of transcriptional regulation by yin yang 1","volume":"8","author":"Verheul","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jep.2024.117857_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","article-title":"Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration","volume":"11","author":"Verma","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jep.2024.117857_bib70","first-page":"3270","article-title":"Study on the protective effects of Bushen Zhichan prescription on dopaminergic neurons in 6-hydroxydopamine-induced Parkinson's disease model","volume":"22","author":"Wang","year":"2020","journal-title":"Modernization of Traditional Chinese Medicine and Materia Materia-World Science and Technology"},{"key":"10.1016\/j.jep.2024.117857_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.585584","article-title":"Molecular mechanisms of glutamate toxicity in Parkinson's disease","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jep.2024.117857_bib72","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41467-020-14788-x","article-title":"Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2024.117857_bib73","first-page":"1086","article-title":"SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease","volume":"123","author":"Xie","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jep.2024.117857_bib74","first-page":"283","article-title":"Effect of Liuwei Dihuang Pill for autonomic symptoms in Parkinson's disease","volume":"25","author":"Xue","year":"2010","journal-title":"Acta Chinese Medicine"},{"key":"10.1016\/j.jep.2024.117857_bib75","first-page":"540","article-title":"Discussion on pathogenesis essence of Parkinson's disease based on distribution regularity of TCM syndrome elements of 300 cases","volume":"32","author":"Yang","year":"2016","journal-title":"J. Nanjing Univ. Tradit. Chin. Med."},{"key":"10.1016\/j.jep.2024.117857_bib76","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1038\/ncomms6627","article-title":"Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF","volume":"5","author":"Yang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2024.117857_bib77","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12975-019-00708-9","article-title":"NDRG2 protects the brain from excitotoxicity by facilitating interstitial glutamate uptake","volume":"11","author":"Yin","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.jep.2024.117857_bib78","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s11033-020-05272-2","article-title":"Protocol for purification and culture of astrocytes: useful not only in 2 days postnatal but also in adult rat brain","volume":"47","author":"ZareiKheirabadi","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jep.2024.117857_bib79","first-page":"256","article-title":"Clinical observation on Bushen Zhiquan decoction granules in treatment of Parkinson's disease of liver and kidney deficiency","volume":"36","author":"Zhang","year":"2021","journal-title":"Drugs & Clinic"},{"key":"10.1016\/j.jep.2024.117857_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8941327","article-title":"Recent advance in the relationship between excitatory amino acid transporters and Parkinson's disease","volume":"2016","author":"Zhang","year":"2016","journal-title":"Neural Plast."}],"updated-by":[{"DOI":"10.1016\/j.jep.2024.118023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000}}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874124001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874124001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:53:37Z","timestamp":1729097617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874124001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":80,"alternative-id":["S0378874124001569"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2024.117857","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jep.2024.118023","asserted-by":"object"}]},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic study of the anti-excitatory amino acid toxicity of Bushen Zhichan decoction for Parkinson's disease based on the transcriptional regulation of EAAT1 by YY1","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2024.117857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117857"}}